NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/26/2026
Back to search
Official data from USPTO
SKINVIVAID
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
SKINVIVAID
ST13
US500000079306431Class
9, 42, 44
Filing
79306431
Registration
6829624
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
02/27/2026
Classification
Registered
Trademark type
Word
Nice classes
9, 42, 44
Filing date
12/14/2020
Registration date
08/30/2022
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/30/2022
Last transaction
02/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
GB
Examiner
FLETCHER, TRACY L
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Genesis Specialist Care Holding UK Limited
Representatives
Andrew S. Ehard
Technical classification
Nice Classes
Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software for assessing the severity of skin cancerization and damage for use in relation to pre-cancer treatment servicescancer treatment servicesradiation therapy services; electronic publicationsdownloadable magazinesbooksnewslettersarticles in the field of medicine; electronic publications relating to medical mattersdownloadable magazinesbooksnewslettersarticles in the field of medicine; digital downloadable questionnaires for medical assessments; downloadable computer software for assessing the severity of skin cancerization and damage for use in relation to pre-cancer treatment servicescancer treatment servicesradiation therapy services in the diagnosismonitoring and treatment of medical and health conditions; downloadable computer software for assessing the severity of skin cancerization and damage for use in relation to pre-cancer treatment servicescancer treatment servicesradiation therapy services in the diagnosismonitoring and treatment of skin conditions; downloadable customer relationship management (CRM) computer software for the management of the medical patient experience; computer software providing medical and health contentdownloadable educational computer software featuring medical instruction for use in relation to pre-cancer treatment servicescancer treatment servicesradiation therapy services; computer software providing medical and health content relating to skindownloadable educational computer software featuring medical instruction for use in relation to pre-cancer treatment servicescancer treatment servicesradiation therapy services; computer software for harmonised care management of medical patientsdownloadable computer software for enabling healthcare providers to view patient clinical data across multiple providers and enabling patients to view and download a completedigital medical history for use in relation to pre-cancer treatment servicescancer treatment servicesradiation therapy services; computer software for medical patient administrationdownloadable computer software for enabling healthcare providers to view patient clinical data across multiple providers and sites and enabling patients and healthcare providers to view and download a completedigital medical history
Class 42
Software as a service (SaaS) services featuring software for assessing the severity of skin cancerization and damage for use in relation to pre-cancer treatment servicescancer treatment servicesradiation therapy services; software as a service for the diagnosismonitoring and treatment of medical and health conditionssoftware as a service (SaaS) services featuring software for assessing the severity of skin cancerization and damage for use in relation to pre-cancer treatment servicescancer treatment servicesradiation therapy services; software as a service for the diagnosismonitoring and treatment of skin conditionssoftware as a service (SaaS) services featuring software for assessing the severity of skin cancerization and damage for use in relation to pre-cancer treatment servicescancer treatment servicesradiation therapy services; software as a service (SaaS) services featuring customer relationship management (CRM) software for the management of the medical patient experience; software as a service (SaaS) services featuring software for providing medical and health content in the nature of enabling healthcare providers to view patient clinical data across multiple providers and sites and enabling patients and healthcare providers to view and download a completedigital medical history; software as a service (SaaS) services featuring software for providing medical and health content relating to skin in the nature of enabling healthcare providers to view patient clinical data across multiple providers and sites and enabling patients and healthcare providers to view and download a completedigital medical history; software as a service (SaaS) services featuring software for enabling healthcare providers to view patient clinical data across multiple providers and sites and enabling patients and healthcare providers to view and download a completedigital medical history for harmonised care management of medical patients; software as a service (SaaS) services featuring medical patient administration software for enabling healthcare providers to view patient clinical data across multiple providers and sites and enabling patients and healthcare providers to view and download a completedigital medical history
Class 44
Radiation oncology services; radiation therapy services; medical clinic services; medical treatment services
Publications
History of USPTO decisions and trademark events.
40 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/28/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/07/2022
FIMP
FINAL DISPOSITION PROCESSED
12/07/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/30/2022
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
09/16/2022
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/04/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/30/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
08/30/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/17/2022
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/17/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/14/2022
GPNX
NOTIFICATION PROCESSED BY IB
07/05/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/14/2022
PUBO
PUBLISHED FOR OPPOSITION
06/14/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/08/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/08/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/25/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/10/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
05/10/2022
ALIE
ASSIGNED TO LIE
05/10/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/10/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
05/10/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/10/2022
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/19/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/16/2021
GNFR
FINAL REFUSAL E-MAILED
11/16/2021
CNFR
FINAL REFUSAL WRITTEN
11/16/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/15/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/15/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/15/2021
RFNT
REFUSAL PROCESSED BY IB
07/05/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/14/2021
RFRR
REFUSAL PROCESSED BY MPU
06/14/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/12/2021
CNRT
NON-FINAL ACTION WRITTEN
06/11/2021
DOCK
ASSIGNED TO EXAMINER
06/07/2021
MAFR
APPLICATION FILING RECEIPT MAILED
03/16/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/11/2021
Continuous trademark protection
Get notified about every new filing that threatens SKINVIVAID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.